Showing results (121-130 of 308) with videos related to
Sort By:
Pageof 31
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Reversal of thymic stromal lymphopoietin-induced airway inflammation through inhibition of Th2 responsesBaohua Zhou, Mark B Headley, Theingi Aye, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|February 6, 2026
Optimized primary organotypic culture from murine neonatal tracheal airway epithelial cellsYan Han, Rewa Kulkarni, Stephan Pribitzer, et al.The Journal of Allergy and Clinical Immunology. in Practice|August 6, 2021
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial AllergyJonathan Corren, Christopher S Ambrose, Kinga Sałapa, et al.Proceedings of the National Academy of Sciences of the United States of America|March 9, 2005
De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cellsMindi R Walker, Bryan D Carson, Gerald T Nepom, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2013
Thymic stromal lymphopoietin amplifies the differentiation of alternatively activated macrophagesHongwei Han, Mark B Headley, Whitney Xu, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 22, 2010
Cellular requirements for diabetes induction in DO11.10xRIPmOVA miceJohnna D Wesley, Blythe D Sather, Nikole R Perdue, et al.The Journal of Allergy and Clinical Immunology|July 21, 2022
TSLP, IL-33, and IL-25: Not just for allergy and helminth infectionAlison G Stanbery, Shuchi Smita, Jakob von Moltke, et al.Advances in Pharmacology (San Diego, Calif.)|February 26, 2013
The biology of thymic stromal lymphopoietin (TSLP)Steven F Ziegler, Florence Roan, Bryan D Bell, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
TSLP conditions the lung immune environment for the generation of pathogenic innate and antigen-specific adaptive immune responsesMark B Headley, Baohua Zhou, Weihui X Shih, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 10, 2020
Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAYJonathan Corren, Esther Garcia Gil, Janet M Griffiths, et al.Pageof 31